Hepcidin and DNA promoter methylation in hepatocellular carcinoma

E-ISSN： 1365-2362|48|2|eci.12870-eci.12870

ISSN： 0014-2972

Source： EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol.48, Iss.2, 2018-02, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma

HEPATOLOGY, Vol. 61, Iss. 6, 2015-06 ,pp. : 1945-1956

John Wiley & Sons Inc

Access to resources Recommend Favorite

Silencing of PCDH10 in hepatocellular carcinoma via de novo DNA methylation independent of HBV infection or HBX expression

By Fang Song

Clinical and Experimental Medicine, Vol. 13, Iss. 2, 2013-05 ,pp. : 127-134

Springer Publishing Company

Access to resources Recommend Favorite

Global DNA methylation and hydroxymethylation differ in hepatocellular carcinoma and cholangiocarcinoma and relate to survival rate

HEPATOLOGY, Vol. 62, Iss. 2, 2015-08 ,pp. : 496-504

John Wiley & Sons Inc

Access to resources Recommend Favorite

Aberrant Methylation of the VIM Promoter in Uterine Cervical Squamous Cell Carcinoma

Oncology, Vol. 86, Iss. 5-6, 2014-06 ,pp. : 359-368

Karger

Access to resources Recommend Favorite

Promoter DNA methylation is associated with KLF11 expression in epithelial ovarian cancer

GENES, CHROMOSOMES AND CANCER, Vol. 54, Iss. 7, 2015-07 ,pp. : 453-462

John Wiley & Sons Inc

Access to resources Recommend Favorite